{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:55:24Z","timestamp":1774464924362,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01198-4","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T22:25:20Z","timestamp":1769466320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of HLA Variants Associated with Symptomatic and Asymptomatic COVID-19 Using a Machine Learning Approach"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3443-693X","authenticated-orcid":false,"given":"Atul","family":"Rawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-5188","authenticated-orcid":false,"given":"Zuben","family":"Sauna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"1198_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.econmod.2022.106147","volume":"120","author":"T Walmsley","year":"2023","unstructured":"Walmsley T, et al. Macroeconomic consequences of the COVID-19 pandemic. Econ Model. 2023;120:106147.","journal-title":"Econ Model"},{"issue":"15","key":"1198_CR2","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jama.2020.19759","volume":"324","author":"DM Cutler","year":"2020","unstructured":"Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020;324(15):1495\u20136.","journal-title":"JAMA"},{"issue":"2","key":"1198_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.7326\/L20-1285","volume":"174","author":"DP Oran","year":"2021","unstructured":"Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med. 2021;174(2):286\u20137.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1198_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/thoraxjnl-2020-215042","volume":"76","author":"SH Ra","year":"2021","unstructured":"Ra SH, et al. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax. 2021;76(1):61\u20133.","journal-title":"Thorax"},{"issue":"9","key":"1198_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003346","volume":"17","author":"D Buitrago-Garcia","year":"2020","unstructured":"Buitrago-Garcia D, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003346.","journal-title":"PLoS Med"},{"issue":"7972","key":"1198_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-023-06331-x","volume":"620","author":"DG Augusto","year":"2023","unstructured":"Augusto DG, et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature. 2023;620(7972):128\u201336.","journal-title":"Nature"},{"issue":"7","key":"1198_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","volume":"5","author":"M Madjid","year":"2020","unstructured":"Madjid M, et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831\u201340.","journal-title":"JAMA Cardiol"},{"key":"1198_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb2506929","author":"V Prasad","year":"2025","unstructured":"Prasad V, Makary MA, Mass Medical Soc. An evidence-based approach to COVID-19 vaccination. N Engl J Med. 2025. https:\/\/doi.org\/10.1056\/NEJMsb2506929.","journal-title":"N Engl J Med"},{"issue":"3","key":"1198_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583\u201390.","journal-title":"Nat Med"},{"key":"1198_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","volume":"8","author":"M Wieczorek","year":"2017","unstructured":"Wieczorek M, et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol. 2017;8:292.","journal-title":"Front Immunol"},{"issue":"1","key":"1198_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/tan.14284","volume":"98","author":"DJ Langton","year":"2021","unstructured":"Langton DJ, et al. The influence of HLA genotype on the severity of COVID\u201019 infection. HLA. 2021;98(1):14\u201322.","journal-title":"HLA"},{"key":"1198_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-021-00563-1","volume":"26","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, et al. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res. 2021;26:1\u20139.","journal-title":"Eur J Med Res"},{"key":"1198_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.601886","volume":"11","author":"F Tavasolian","year":"2021","unstructured":"Tavasolian F, et al. HLA, immune response, and susceptibility to COVID-19. Front Immunol. 2021;11:601886.","journal-title":"Front Immunol"},{"key":"1198_CR14","doi-asserted-by":"publisher","unstructured":"Nguyen A, et al. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol. 2020. https:\/\/doi.org\/10.1128\/jvi.00510-20.","DOI":"10.1128\/jvi.00510-20"},{"key":"1198_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02515-5","volume":"18","author":"S Pisanti","year":"2020","unstructured":"Pisanti S, et al. Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19. J Transl Med. 2020;18:1\u201316.","journal-title":"J Transl Med"},{"key":"1198_CR16","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.3389\/fimmu.2019.02894","volume":"10","author":"JR McGill","year":"2019","unstructured":"McGill JR, et al. SampPick: selection of a cohort of subjects matching a population HLA distribution. Front Immunol. 2019;10:2894.","journal-title":"Front Immunol"},{"key":"1198_CR17","doi-asserted-by":"publisher","unstructured":"Lazim NM, Abdullah B. Risk factors and etiopathogenesis of nasopharyngeal carcinoma. In: An evidence-based approach to the management of nasopharyngeal cancer. Academic Press; 2020. pp. 11\u201330. https:\/\/doi.org\/10.1016\/B978-0-12-814403-9.00002-1","DOI":"10.1016\/B978-0-12-814403-9.00002-1"},{"issue":"6","key":"1198_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41431-020-0636-6","volume":"28","author":"org, C.-H.G.I.a.b.","year":"2020","unstructured":"org, C.-H.G.I.a.b. The COVID-19 host genetics initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet. 2020;28(6):715\u20138.","journal-title":"Eur J Hum Genet"},{"key":"1198_CR19","doi-asserted-by":"crossref","unstructured":"Karuppiah B. Immunogenetic landscape of COVID-19 infections related neurological complications. In: COVID-19 in Alzheimer\u2019s Disease and Dementia. 2023. p. 133.","DOI":"10.1016\/B978-0-443-15256-6.00009-X"},{"key":"1198_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ins.2018.06.056","volume":"465","author":"G Douzas","year":"2018","unstructured":"Douzas G, Bacao F, Last F. Improving imbalanced learning through a heuristic oversampling method based on k-means and SMOTE. Inf Sci. 2018;465:1\u201320.","journal-title":"Inf Sci"},{"issue":"3","key":"1198_CR21","volume":"8","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Sun B. Adaptive K-means clustering based under-sampling methods to solve the class imbalance problem. Data Inf Manag. 2024;8(3):100064.","journal-title":"Data Inf Manag"},{"key":"1198_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56090455","author":"HSR Rajula","year":"2020","unstructured":"Rajula HSR, et al. Comparison of conventional statistical methods with machine learning in medicine: diagnosis, drug development, and treatment. Medicina Kaunas. 2020. https:\/\/doi.org\/10.3390\/medicina56090455.","journal-title":"Medicina Kaunas"},{"issue":"12","key":"1198_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s10038-020-0808-9","volume":"65","author":"Y Toyoshima","year":"2020","unstructured":"Toyoshima Y, et al. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020;65(12):1075\u201382.","journal-title":"J Hum Genet"},{"issue":"1-2","key":"1198_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25005","volume":"38","author":"T Hoseinnezhad","year":"2024","unstructured":"Hoseinnezhad T, et al. The role of HLA genetic variants in COVID\u201019 susceptibility, severity, and mortality: a global review. J Clin Lab Anal. 2024;38(1\u20132):e25005.","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"1198_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s10038-020-0771-5","volume":"65","author":"K Kiyotani","year":"2020","unstructured":"Kiyotani K, et al. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. J Hum Genet. 2020;65(7):569\u201375.","journal-title":"J Hum Genet"},{"issue":"11","key":"1198_CR26","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3390\/vaccines10111840","volume":"10","author":"N Prasad","year":"2022","unstructured":"Prasad N, et al. Association of human leucocyte antigen polymorphism with coronavirus disease 19 in renal transplant recipients. Vaccines. 2022;10(11):1840.","journal-title":"Vaccines"},{"issue":"1","key":"1198_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2378","volume":"33","author":"Z Dobrijevi\u0107","year":"2023","unstructured":"Dobrijevi\u0107 Z, et al. The association of human leucocyte antigen (HLA) alleles with COVID\u201019 severity: a systematic review and meta\u2010analysis. Rev Med Virol. 2023;33(1):e2378.","journal-title":"Rev Med Virol"},{"key":"1198_CR28","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20248","volume":"150","author":"A Sanchez-Mazas","year":"2020","unstructured":"Sanchez-Mazas A. HLA studies in the context of coronavirus outbreaks. Swiss Med Wkly. 2020;150:w20248.","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"1198_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/idr16020029","volume":"16","author":"L Naidoo","year":"2024","unstructured":"Naidoo L, Arumugam T, Ramsuran V. Narrative review explaining the role of HLA-A, -B, and -C molecules in COVID-19 disease in and around Africa. Infect Dis Rep. 2024;16(2):380\u2013406.","journal-title":"Infect Dis Rep"},{"key":"1198_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101099","author":"J Weiner","year":"2021","unstructured":"Weiner J. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101099.","journal-title":"EClinicalMedicine"},{"issue":"24","key":"1198_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247695","volume":"13","author":"B Tymoniuk","year":"2024","unstructured":"Tymoniuk B, et al. Associations between clinical manifestations of SARS-CoV-2 infection and HLA alleles in a Caucasian population: a molecular HLA typing study. J Clin Med. 2024;13(24):7695.","journal-title":"J Clin Med"},{"issue":"1","key":"1198_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/imm.13450","volume":"166","author":"S Astbury","year":"2022","unstructured":"Astbury S, et al. HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19. Immunology. 2022;166(1):68\u201377.","journal-title":"Immunology"},{"issue":"4","key":"1198_CR33","first-page":"99","volume":"10","author":"E Troshina","year":"2022","unstructured":"Troshina E, et al. Association of alleles of human leukocyte antigen class II genes and severity of COVID-19 in patients of the \u2018Red Zone\u2019 of the Endocrinology Research Center, Moscow, Russia. Dis. 2022;10(4):99.","journal-title":"Dis"},{"issue":"1","key":"1198_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s43042-023-00390-5","volume":"24","author":"M Fakhkhari","year":"2023","unstructured":"Fakhkhari M, Caidi H, Sadki K. HLA alleles associated with COVID-19 susceptibility and severity in different populations: a systematic review. Egypt J Med Hum Genet. 2023;24(1):10.","journal-title":"Egypt J Med Hum Genet"},{"key":"1198_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101099","author":"J Weiner","year":"2021","unstructured":"Weiner J, et al. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01. EClinicalMedicine. 2021. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101099.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1198_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40001-021-00563-1","volume":"26","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, et al. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res. 2021;26(1):84.","journal-title":"Eur J Med Res"},{"issue":"71","key":"1198_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo1303","volume":"7","author":"S Vardhana","year":"2022","unstructured":"Vardhana S, et al. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci Immunol. 2022;7(71):eabo1303.","journal-title":"Sci Immunol"},{"issue":"1","key":"1198_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine T, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158-168. e14.","journal-title":"Cell"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01198-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:35:06Z","timestamp":1774460106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1198"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01198-4","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Authors used AI\/ML techniques to classify the HLAs then XAI to highlight the op HLAs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"55"}}